Bipolar Disorder
Definition | Aetiology | Pathophysiology | Risk factors | Signs and symptoms | Investigations | Management
Definition
Bipolar Disorder is a chronic psychiatric condition characterised by recurrent episodes of mania and depression, significantly impacting mood, behaviour, and daily functioning.
Aetiology
- Genetic factors: strong hereditary component with multiple risk-associated genes.
- Neurochemical imbalances: dysregulation of dopamine, serotonin, and noradrenaline.
- Neurobiological abnormalities: altered limbic system activity and prefrontal cortex dysfunction.
- Psychosocial factors: stress, trauma, sleep disturbances, and lifestyle factors.
Pathophysiology
- Abnormal neurotransmitter regulation, particularly dopamine and serotonin.
- Increased activity in limbic structures during manic episodes.
- Reduced grey matter volume in the prefrontal cortex, affecting mood regulation.
- Disruptions in circadian rhythm and sleep-wake cycle.
Risk factors
- Family history of bipolar disorder or other mood disorders.
- Early life trauma or adverse experiences.
- Substance misuse (e.g., stimulants, alcohol, cannabis).
- Significant psychosocial stressors.
- Sleep disturbances or circadian rhythm dysfunction.
Signs and symptoms
- Manic episodes:
- Euphoric or irritable mood.
- Increased energy and reduced need for sleep.
- Racing thoughts, pressured speech.
- Grandiosity and inflated self-esteem.
- Risk-taking behaviour (e.g., excessive spending, substance use).
- Depressive episodes:
- Persistent low mood and anhedonia.
- Fatigue, hypersomnia or insomnia.
- Feelings of worthlessness or excessive guilt.
- Difficulty concentrating or making decisions.
- Suicidal ideation or self-harm.
- Mixed episodes: features of both mania and depression occurring simultaneously.
Investigations
- Comprehensive psychiatric assessment: history and mental state examination.
- Structured diagnostic tools: Mood Disorder Questionnaire (MDQ), Young Mania Rating Scale (YMRS).
- Collateral history: from family, friends, or caregivers.
- Blood tests: FBC, U&Es, LFTs, TFTs, vitamin B12, folate to exclude organic causes.
- Urine drug screen: to rule out substance-induced mood symptoms.
- Neuroimaging (MRI/CT): if neurological pathology suspected.
Management
1. Pharmacological management:
- Acute mania:
- First-line: Atypical antipsychotics (e.g., olanzapine, risperidone, quetiapine).
- Second-line: Mood stabilisers (e.g., lithium, valproate).
- Short-term benzodiazepines for severe agitation.
- Depressive episodes:
- Quetiapine or lamotrigine.
- Antidepressants are used cautiously and usually in combination with a mood stabiliser.
- Long-term maintenance:
- Lithium as first-line prophylactic treatment.
- Valproate or lamotrigine as alternatives.
2. Psychological and social interventions:
- Cognitive Behavioural Therapy (CBT) for relapse prevention.
- Interpersonal and social rhythm therapy to stabilise mood.
- Family-focused therapy and psychoeducation.
3. Lifestyle modifications:
- Regular sleep routine to stabilise circadian rhythms.
- Avoidance of stimulants and alcohol.
- Stress management techniques.
4. Crisis and referral management:
- Crisis team referral: if acute suicidal risk.
- Community mental health team (CMHT): for long-term follow-up.
- Hospital admission: if severe mania or suicidality.